Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

• Status: Completed
• Trial end date: 2015-08-22

Summary

This study is being conducted to compare the safety and efficacy of icatibant with placebo in the treatment for Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults.

• Phase: Phase 3

Details

• Lead Sponsor: Shire
• Collaborator: PPD
• Treatments: Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Enzyme Inhibitors; Icatibant